Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 13/20 | 0.51 |
| ▸ | CTSD | P07339 | 4/20 | 0.51 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.45 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29723110 | 0.88 | BACE1 (0.46) | BACE1CTSDENPEP | |
| SCHEMBL30390137 | 0.86 | ENPEP (0.53) | ENPEP | |
| SCHEMBL32673741 | 0.86 | BACE1 (0.51) | BACE1CTSDENPEP | |
| SCHEMBL29888685 | 0.85 | ENPEP (0.57) | BACE1ENPEP | |
| SCHEMBL29722975 | 0.85 | ENPEP (0.46) | BACE1CTSDENPEP | |
| SCHEMBL29641759 | 0.83 | BACE1 (0.55) | BACE1CTSDENPEP | |
| SCHEMBL29882665 | 0.83 | BACE1 (0.58) | BACE1CTSDENPEP | |
| SCHEMBL31474507 | 0.82 | PDCD1LG2 (0.52) | BACE1CTSDENPEP | |
| SCHEMBL6515067 | 0.82 | BACE1 (0.49) | BACE1CTSDENPEP | |
| SCHEMBL29723069 | 0.82 | PDCD1LG2 (0.52) | BACE1CTSDENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250188115-A1 | PROCESS FOR PREPARING A GLUCAGON-LIKE PEPTIDE | CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S.A. (GR) | 2025-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250188115-A1 | PROCESS FOR PREPARING A GLUCAGON-LIKE PEPTIDE | GLP1R, IAPP, GCG | BACE1 404/4885CTSD 2078/4885ENPEP 51/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.